Barry Kappel is the founder of Sapience Therapeutics. Sapience Therapeutics has raised $64M in total funding. Latest round: Series B.
Barry Kappel, Ph.D., M.B.A., is the founder, President, Chief Executive Officer, and Director of Sapience Therapeutics, a clinical-stage biotechnology company that he founded in October 2015. The company focuses on developing peptide-based therapeutics for high-mortality cancers, targeting previously 'undruggable' proteins involved in protein-protein interactions.
Full founder directory · Investor directory · Company funding database · Fundraising library